Your browser doesn't support javascript.
loading
Effectiveness of dasatinib in accelerated-phase chronic myeloid leukemia with p190 BCR-ABL1 and a second Philadelphia chromosome.
Rabenau, Karen E; Dolan, Michelle; Yohe, Sophia; Ustun, Celalettin.
Affiliation
  • Rabenau KE; Department of Medicine, University of Minnesota, Minneapolis, MN, USA.
  • Dolan M; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.
  • Yohe S; Division of Hematology-Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA.
  • Ustun C; Division of Hematology-Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA. Electronic address: custun@umn.edu.
Cancer Genet ; 207(3): 109-10, 2014 Mar.
Article in En | MEDLINE | ID: mdl-24703333

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Thiazoles / Philadelphia Chromosome / Leukemia, Myeloid, Accelerated Phase / Fusion Proteins, bcr-abl / Antineoplastic Agents Limits: Humans Language: En Journal: Cancer Genet Year: 2014 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Thiazoles / Philadelphia Chromosome / Leukemia, Myeloid, Accelerated Phase / Fusion Proteins, bcr-abl / Antineoplastic Agents Limits: Humans Language: En Journal: Cancer Genet Year: 2014 Document type: Article Affiliation country: United States